Short Interest in Fresenius SE & Co. (OTCMKTS:FSNUY) Increases By 375.6%

Posted by Latisha Jones on Jul 13th, 2026

Fresenius SE & Co. (OTCMKTS:FSNUY – Get Free Report) was the target of a significant increase in short interest in the month of June. As of June 30th, there was short interest totaling 282,012 shares, an increase of 375.6% from the June 15th total of 59,293 shares. Based on an average trading volume of 392,720 shares, the short-interest ratio is currently 0.7 days. Approximately 0.0% of the company’s stock are sold short.

Wall Street Analysts Forecast Growth

Separately, Morgan Stanley reissued an “overweight” rating on shares of Fresenius SE & Co. in a research report on Tuesday, June 23rd. Three investment analysts have rated the stock with a Buy rating, According to data from MarketBeat.com, the stock has an average rating of “Buy”.

Check Out Our Latest Research Report on Fresenius SE & Co.

Fresenius SE & Co. Stock Performance

FSNUY stock traded down $0.30 during midday trading on Monday, reaching $11.88. 597,542 shares of the company were exchanged, compared to its average volume of 137,844. Fresenius SE & Co. has a one year low of $10.33 and a one year high of $33.93. The firm has a market capitalization of $26.77 billion, a price-to-earnings ratio of 15.84 and a beta of 0.63. The business has a 50-day moving average price of $11.42 and a two-hundred day moving average price of $13.01. The company has a debt-to-equity ratio of 0.41, a current ratio of 1.27 and a quick ratio of 0.98.

Fresenius SE & Co. (OTCMKTS:FSNUY – Get Free Report) last posted its earnings results on Wednesday, May 6th. The company reported $0.24 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.25 by ($0.01). The company had revenue of $6.75 billion for the quarter, compared to analyst estimates of $6.79 billion. Fresenius SE & Co. had a return on equity of 10.09% and a net margin of 6.55%. Equities research analysts forecast that Fresenius SE & Co. will post 1.03 EPS for the current year.

About Fresenius SE & Co.

(Get Free Report)

Fresenius SE & Co KGaA is a global healthcare group headquartered in Bad Homburg vor der Höhe, Germany. Founded in 1912 by Eduard Fresenius, the company has grown into one of the world’s leading providers of products and services for dialysis, hospitals and outpatient medical care. Trading on major European exchanges and available over the counter in the U.S. as FSNUY, Fresenius SE & Co brings together a portfolio of specialized healthcare businesses under one corporate umbrella.

The company operates through four main business segments.